INTRODUCTION: Gastrointestinal (GI) side-effects occur frequently as a result of immunosuppressant regimens used in renal transplant patients. Little effort has been made to quantify the impact of these side-effects on patients' health-related quality of life and symptom severity. OBJECTIVE: To assess the psychometric characteristics of two GI-specific outcome instruments (the Gastrointestinal Rating Scale (GSRS) and the Gastrointestinal Quality of Life Index (GIQLI)) for use in post-renal transplant patients. METHODS: Cross-sectional study conducted at 5 clinical centers in 4 countries. Patients were required to be on mycophenolate mofetil and a calcineurin inhibitor. Patients completed the GSRS, GIQLI and two generic instruments (the Psychological General Well-Being Index and the EQ-5D) at one timepoint. Reliability, construct and known groups validity were assessed. RESULTS: In general the GSRS and the GIQLI demonstrated Cronbach's alphas higher than 0.70. The GIQLI was moderately to highly correlated with the PGWB and EQ-5D. Correlations among the GSRS and generic instruments were slightly lower. The GSRS and GIQLI both distinguished between patients with and without GI complaints (all p<0.05). CONCLUSIONS: The GSRS and the GIQLI are appropriate for use in a post-renal transplant population. Scores on both instruments demonstrated significant differences between renal transplant patients with GI complications and without GI complications.
INTRODUCTION: Gastrointestinal (GI) side-effects occur frequently as a result of immunosuppressant regimens used in renal transplant patients. Little effort has been made to quantify the impact of these side-effects on patients' health-related quality of life and symptom severity. OBJECTIVE: To assess the psychometric characteristics of two GI-specific outcome instruments (the Gastrointestinal Rating Scale (GSRS) and the Gastrointestinal Quality of Life Index (GIQLI)) for use in post-renal transplant patients. METHODS: Cross-sectional study conducted at 5 clinical centers in 4 countries. Patients were required to be on mycophenolate mofetil and a calcineurin inhibitor. Patients completed the GSRS, GIQLI and two generic instruments (the Psychological General Well-Being Index and the EQ-5D) at one timepoint. Reliability, construct and known groups validity were assessed. RESULTS: In general the GSRS and the GIQLI demonstrated Cronbach's alphas higher than 0.70. The GIQLI was moderately to highly correlated with the PGWB and EQ-5D. Correlations among the GSRS and generic instruments were slightly lower. The GSRS and GIQLI both distinguished between patients with and without GI complaints (all p<0.05). CONCLUSIONS: The GSRS and the GIQLI are appropriate for use in a post-renal transplant population. Scores on both instruments demonstrated significant differences between renal transplant patients with GI complications and without GI complications.
Authors: Neil Aaronson; Jordi Alonso; Audrey Burnam; Kathleen N Lohr; Donald L Patrick; Edward Perrin; Ruth E Stein Journal: Qual Life Res Date: 2002-05 Impact factor: 4.147
Authors: A O Ojo; H U Meier-Kriesche; J A Hanson; A B Leichtman; D Cibrik; J C Magee; R A Wolfe; L Y Agodoa; B Kaplan Journal: Transplantation Date: 2000-06-15 Impact factor: 4.939
Authors: Ronald P Pelletier; Baris Akin; Mitchell L Henry; Ginny L Bumgardner; Elmahdi A Elkhammas; Amer Rajab; Ronald M Ferguson Journal: Clin Transplant Date: 2003-06 Impact factor: 2.863
Authors: Jade E Kenna; Megan C Bakeberg; Anastazja M Gorecki; Alfred Chin Yen Tay; Samantha Winter; Frank L Mastaglia; Ryan S Anderton Journal: Mov Disord Clin Pract Date: 2021-01-05
Authors: Yiman Wang; Jaapjan D Snoep; Marc H Hemmelder; Koen E A van der Bogt; Willem Jan W Bos; Paul J M van der Boog; Friedo W Dekker; Aiko P J de Vries; Yvette Meuleman Journal: Clin Kidney J Date: 2021-01-20
Authors: Jong Man Kim; Choon Hyuck David Kwon; Ik Jin Yun; Kwang-Woong Lee; Hee Chul Yu; Kyung-Suk Suh; Jae-Won Joh; Baik Hwan Cho Journal: Ann Surg Treat Res Date: 2014-03-25 Impact factor: 1.859
Authors: Olalekan Lee Aiyegbusi; Derek Kyte; Paul Cockwell; Tom Marshall; Adrian Gheorghe; Thomas Keeley; Anita Slade; Melanie Calvert Journal: PLoS One Date: 2017-06-21 Impact factor: 3.240
Authors: Gerardo Machnicki; Jacqueline Pefaur; Luis Gaite; Ana M Linchenco; Clemente Raimondi; Ruben Schiavelli; Alcira Otero; Mary Kay Margolis Journal: Health Qual Life Outcomes Date: 2008-07-21 Impact factor: 3.186
Authors: Rocco C Venuto; Calvin J Meaney; Shirley Chang; Nicolae Leca; Joseph D Consiglio; Gregory E Wilding; Daniel Brazeau; Aijaz Gundroo; Neha Nainani; Sarah E Morse; Louise M Cooper; Kathleen M Tornatore Journal: Medicine (Baltimore) Date: 2015-09 Impact factor: 1.817